These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19751470)

  • 1. Protein-energy malnutrition as a risk factor for visceral leishmaniasis: a review.
    Malafaia G
    Parasite Immunol; 2009 Oct; 31(10):587-96. PubMed ID: 19751470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Visceral leishmaniasis and malnutrition: a case report].
    Hida M; Mouane N; Ettair S; Erreimi N; Malihy A; Agoumi A; Bouchta F
    Arch Pediatr; 1999 Mar; 6(3):290-2. PubMed ID: 10191897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunopathogenesis of Leishmania infections].
    Yurdakul P
    Mikrobiyol Bul; 2005 Jul; 39(3):363-81. PubMed ID: 16358498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmaniasis: current situation and new perspectives.
    Desjeux P
    Comp Immunol Microbiol Infect Dis; 2004 Sep; 27(5):305-18. PubMed ID: 15225981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-energy malnutrition decreases immune response to Leishmania chagasi vaccine in BALB/c mice.
    Malafaia G; Serafim TD; Silva ME; Pedrosa ML; Rezende SA
    Parasite Immunol; 2009 Jan; 31(1):41-9. PubMed ID: 19121082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of some metabolic changes in protein-energy malnutrition.
    Akuyam SA
    Niger Postgrad Med J; 2007 Jun; 14(2):155-62. PubMed ID: 17599117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of lymphocyte subpopulations in bone marrow in a model of protein-energy malnutrition.
    Fock RA; Blatt SL; Beutler B; Pereira J; Tsujita M; de Barros FE; Borelli P
    Nutrition; 2010 Oct; 26(10):1021-8. PubMed ID: 20036516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Visceral leishmaniasis of intestinal localization without initial splenomegaly in malnutrition in a child].
    Mikou N; Balafrej A; Belabbes M; Benhammou B; Mikou S
    Arch Fr Pediatr; 1992 Jan; 49(1):68. PubMed ID: 1550458
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune response to leishmania: paradox rather than paradigm.
    Tripathi P; Singh V; Naik S
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):229-42. PubMed ID: 17714488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of visceral leishmaniasis in the Tharaka District, Kenya.
    Pelizzi M; Verna M; Vanelli M
    Acta Biomed; 2006 Aug; 77(2):103-5. PubMed ID: 17172190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of K39 strip test in visceral leishmaniasis (VL) and HIV co-infected patients: an early report from Eastern India.
    Goswami RP; Rahman M; Guha SK
    J Assoc Physicians India; 2007 Feb; 55():154-5. PubMed ID: 17571750
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein-energy malnutrition: a risk factor for various ailments.
    Batool R; Butt MS; Sultan MT; Saeed F; Naz R
    Crit Rev Food Sci Nutr; 2015; 55(2):242-53. PubMed ID: 24915388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiology of leishmaniasis.
    Sharma U; Singh S
    Indian J Exp Biol; 2009 Jun; 47(6):412-23. PubMed ID: 19634705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vector incrimination of sand flies in the most important visceral leishmaniasis focus in Iran.
    Oshaghi MA; Ravasan NM; Javadian EA; Mohebali M; Hajjaran H; Zare Z; Mohtarami F; Rassi Y
    Am J Trop Med Hyg; 2009 Oct; 81(4):572-7. PubMed ID: 19815868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malnutrition, age and the risk of parasitic disease: visceral leishmaniasis revisited.
    Dye C; Williams BG
    Proc Biol Sci; 1993 Oct; 254(1339):33-9. PubMed ID: 8265673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal parasitic infections and micronutrient deficiency: a review.
    Hesham MS; Edariah AB; Norhayati M
    Med J Malaysia; 2004 Jun; 59(2):284-93. PubMed ID: 15559182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis in captive wild canids in Brazil.
    Luppi MM; Malta MC; Silva TM; Silva FL; Motta RO; Miranda I; Ecco R; Santos RL
    Vet Parasitol; 2008 Aug; 155(1-2):146-51. PubMed ID: 18556130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileishmania antibodies and functional activity of complement components in patients with visceral leishmaniasis in Kenya.
    Koech DK; Lyerly WH; Iha DW
    East Afr Med J; 1982 Oct; 59(10):665-70. PubMed ID: 7185558
    [No Abstract]   [Full Text] [Related]  

  • 19. Live attenuated Leishmania vaccines: a potential strategic alternative.
    Silvestre R; Cordeiro-da-Silva A; Ouaissi A
    Arch Immunol Ther Exp (Warsz); 2008; 56(2):123-6. PubMed ID: 18373245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments in the treatment of visceral leishmaniasis.
    den Boer ML; Alvar J; Davidson RN; Ritmeijer K; Balasegaram M
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):395-410. PubMed ID: 19708817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.